13F filer · CIK 1569064
MONTANOVA CAPITAL, LLC
New York, NY · filing since Q4 2013 · last filing Aug 14, 2026
Reported value
$5.5B
+$1.6B vs prior
Positions
96
New / sold out
21 / 14
Added / reduced
26 / 17
Turnover
12.6%
buys $1.2B · sells $589.6M
Top-10 weight
49.1%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | SPYSTATE STR SPDR S&P 500 ETF TPUT | +600,000 | +171.4% | +$448.1M |
| New | AVALYN PHARMACEUTICALS INC | +2,503,109 | – | +$82.4M |
| New | HUT 8 CORP | +670,000 | – | +$77.3M |
| Added | FAETH THERAPEUTICS INC | +1,985,554 | +5747.1% | +$49.6M |
| New | AMPHENOL CORP | +269,300 | – | +$47.5M |
| Added | SPOTIFY TECHNOLOGY S A | +100,700 | +9154.5% | +$46.2M |
| New | ROUNDHILL ETF TRUST | +603,000 | – | +$44.5M |
| New | CEREBRAS SYSTEMS INC | +171,900 | – | +$38.0M |
| New | DICKS SPORTING GOODS INC | +151,320 | – | +$34.3M |
| Added | INFLARX NV | +15,000,000 | +189.1% | +$33.6M |
37 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | APELLIS PHARMACEUTICALS INC | -3,518,471 | -100.0% | $-141.5M |
| Sold out | KALVISTA PHARMACEUTICALS INC | -4,768,712 | -100.0% | $-96.0M |
| Sold out | ERASCA INC | -3,434,967 | -100.0% | $-55.6M |
| Reduced | PERFORMANCE FOOD GROUP CO | -372,175 | -96.2% | $-41.6M |
| Reduced | US FOODS HLDG CORP | -389,050 | -98.3% | $-39.8M |
| Reduced | MINERALYS THERAPEUTICS INC | -1,364,776 | -88.7% | $-36.8M |
| Reduced | BACBANK OF AMER CORP | -505,525 | -39.0% | $-28.8M |
| Reduced | MONTE ROSA THERAPEUTICS INC | -677,270 | -16.0% | $-16.4M |
| Reduced | UNITEDHEALTH GROUP INC | -36,500 | -36.3% | $-15.2M |
| Reduced | LEGEND BIOTECH CORP | -511,029 | -6.7% | $-14.8M |
21 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SPYSTATE STR SPDR S&P 500 ETF TPUT | 950,000 | $709.4M | 12.97% |
| 2 | VERADERMICS INCCOMMON STOCK | 4,168,970 | $512.5M | 9.37% |
| 3 | ARCUTIS BIOTHERAPEUTICS INCCOM | 12,437,000 | $326.1M | 5.96% |
| 4 | LEGEND BIOTECH CORPSPONSORED ADS | 7,070,000 | $204.2M | 3.73% |
| 5 | PALVELLA THERAPEUTICS INC NECOM | 1,135,406 | $173.5M | 3.17% |
| 6 | ARRIVENT BIOPHARMA INCCOM | 4,515,531 | $156.9M | 2.87% |
| 7 | BENITEC BIOPHARMA INCCOM NEW | 11,548,351 | $154.5M | 2.83% |
| 8 | BIOHAVEN LTDCOM | 10,286,937 | $153.1M | 2.80% |
| 9 | ADVANCED MICRO DEVICES INCCOM | 257,240 | $149.4M | 2.73% |
| 10 | ARCUS BIOSCIENCES INCCOM | 4,776,423 | $147.3M | 2.69% |
86 more rows. Subscribe for $29/month to see every row, download the data and use the API.